Your solution to treat
local wound infection should be
Effective → Accessible → Easy, safe & pain-free
Maintain a clean wound bed with continuous debridement while the dressing is in place
Test your knowledge:
Take our debridement quiz
Implement continuous debridement
into practice: New consensus report
on Wound Bed Preparation
Product Benefits
• Enables continuous debridement of slough 1, 2, 3
• Destroys and disrupts biofilm 4, 5
• Fights against signs of local infection 4, 5
Making debridement accessible for every clinician
Your simple evidence based guide to debridement - saving clinician time and reducing waste.
Supports every care setting
For all staff in any environment - helping standardise evidence-based care even when time and resources are limited.
UrgoClean Ag delivers continuous debridement
UrgoClean Ag provides continuous debridement, removing barriers to healing while the dressing is in place, unlike one-off clinical debridement.
.
"Debridement through dressing use provides an ideal step in WBP that can be carried out in all settings by all staff, simplifying practice and improving outcomes."
Read how leading clinicians are redefining wound bed preparation - and how UrgoClean Ag is setting a new standard for simplicity, consistency, and clinical effectiveness.
References:
1. Meaume S., Dissemond J,. et al, Evaluation of two fibrous wound dressings for the management of leg ulcers: Results of a European randomised controlled trial (Earth RCT). J Wound Care, Vol 23. No 3; March 2014, 105-116. Study conducted on UrgoClean Pad.
2. Dalac S., Sigal L., Addala A., et al Clinical evaluation of a dressing with poly absorbent fibres and a silver matrix for managing chronic wounds at risk of infection: a non comparative trial. J Wound Care, Vol 25, No 9, September 2016. No or minor pain at removal in 74% of dressing changes.
3. Dissemond J, Dietlein M, NeβELER L, Funke L, Scheuermann O, Becker E, Thomassin L, Möller U, Bohbot S, Múnter KC. Use of a TLC-Ag dressing on 2270 patients with wounds at risk or with signs of local infection: an observational study. J Wound Care. 2020,Mar 2;29(3):162-173. doi: 10,12968/jowc2020.29.3.162. PMID: 32160091. At final visit no or slight/short pain at removal in 67.2% of the patients. Painless at removal in 75% of paediatric patients
4. UrgoClean Ag, in vitro reports, data on file
5. Desroche N, Dropet C, Janod P, et al. Antibacterial properties and reduction of MRSA biofilm with a dressing combining polyabsorbent fibres and a silver matrix. J Wound Care 2016; 25: 577-584.
UrgoClean Ag: Meducal Device CE 2797. Read the patient leaflet before use.